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ABSTRACT 
Background: ECMO is a lifesaving procedure in patients with severe respiratory 
insufficiency failing conventional support. Bleeding complications are common due to the 
necessity for anticoagulation and circuit related factors. 
Methods:  A retrospective review was conducted in patients requiring ECMO for 
respiratory failure from 7/2010 to 6/2011to identity episodes of major bleeding, bleeding 
management and outcomes. 
Results: Twenty-one patients were supported with ECMO during the study, although 5 
experienced massive bleeding related to chest tube insertion, jejunal arterio-venous 
malformations, distal perfusion cannula dislodgement, and ventricular rupture. Patients 
required aggressive resuscitation, endoscopic or operative intervention, totaling 28 
procedures. There were no instances of dehiscence, infection, or sepsis related to 
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interventions. Anticoagulation was stopped 6 hours before and restarted 24 hours after 
major interventions, with no thrombotic or neurologic complications.  All patients weaned 
off ECMO were discharged.   
Conclusions:  ECMO bleeding complications can be managed successfully via surgical 
and endoscopic approaches in this high risk population. 
 
Abstract word count: 148
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INTRODUCTION 
Primary reversible respiratory failure is an indication for ECMO in patients who 
fail conventional respiratory support measures. 1 Bleeding complications are common 
and have been reported in 22-32% of all ECMO supported patients. 2,3A high incidence 
of bleeding can be attributed in part to systemic anticoagulation, circuit induced 
coagulopathies and systemic disease processes, ultimately leading to an increased 
mortality in these ECMO supported patients. 
This paper represents the largest experience reported in the literature pertaining 
to patient survival of massive bleeding complications on ECMO and the standardized 
approach to their management; utilizing an anticoagulation protocol and aggressive 
surgical management.   
 
METHODS 
We performed an Institutional Review Board (IRB) approved review of adult 
patients from July 2010 to June 2011 in the Surgical Cardiac Care Unit of Thomas 
Jefferson University Hospital. Twenty-one patients were supported with ECMO during 
the study period. Of this population, 5 patients (2 females, 3 males) experienced 
massive bleeding related to pre or post ECMO chest tube insertion, jejunal arterio-
venous malformations (AVM), femoral distal limb cannula dislodgement with a superficial 
femoral artery pseudo aneurysm, or ventricular rupture at the time of AvalonTM cannula 
insertion.  Massive bleeding was defined by our hospital’s Massive Transfusion Protocol 
of transfusion of 10 units of packed red blood cells (PRBC) over 24 hours.  Patient data 
was reviewed retrospectively from a prospective data collecting system. Demographic 
data, indications and duration for ECMO, occurrence of cerebral events, heparin 
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protocols, bleeding complications and their management, and short and long-term 
outcomes were reviewed. 
 
VA-ECMO/VV-ECMO Cannulation Method:  
 Twenty-one patients were peripherally cannulated via percutaneous insertion of 
the ECMO cannula using the Seldinger technique. All patients on VV-ECMO were 
cannulated via the internal jugular vein using the AvalonTM Elite Dual Lumen bicaval 
cannula (Avalon Laboratories, Rancho Dominquez, CA). Percutaneous femoral 
cannulation was the preferred placement in all patients on VA-ECMO. Distal arterial 
percutaneous perfusion catheters (5Fr) were placed in all patients with peripheral 
femoral cannulation. 
  The heart and lung support (HLS) cannulae (bio-compatible polyurethane, 
Maquet Cardiovascular LLC, San Jose, CA) were connected to a closed crystalloid 
primed circuit (~500ml); both cannulae and tubing have Bioline heparin coating. The 
circuitry for ECMO consisted of the Quadrox-D diffusion membrane hollow-fiber 
oxygenator (Maquet Cardiovascular LLC, San Jose, CA) and a Rotaflow centrifugal 
pump (Maquet Cardiovascular LLC, San Jose, CA) with a heater exchanger.  
Heparin Protocol 
Whether VV or VA ECMO circuit was used, a bolus of heparin 5000 -7500 units 
was given just after placement of the venous and/or arterial guide wires. No additional 
heparin was given for 24 hours after ECMO was initiated unless clots were observed in 
the circuit. After 24 hours, a heparin infusion was started with a Prothrombin time (PTT) 
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therapeutic goal of 40-45 seconds; on day #2 onwards, PTT therapeutic goal was 45-55 
seconds.   
The ECMO circuit was continuously monitored for thrombi and fibrin formation by 
visual inspection. Provided oxygenation and flow were adequate, circuit exchange was 
not necessary. If thrombi are noted in either the ECMO oxygenator or the patient 
developed hypoxia, the post-oxygenator oxygenation was evaluated. If the oxygenator 
was suspected to be the source of the problem, the circuit was exchanged at the 
bedside.  No additional heparin was used for circuit exchanges.   
All patients with decreased platelets were evaluated for heparin induced 
thrombocytopenia (HIT) and anticoagulation was switched to Argatroban if the HIT panel 
was positive. One patient was suspected to have HIT and temporarily (<24 hours) 
required Argatroban. Argatroban was discontinued within 24 hours when the HIT panel 
(platelet factor-4 and serotonin release assay) was negative. 
Surgical Procedures 
Major and minor procedures were classified according to urgency of the 
procedure. For minor procedures, heparin was stopped 6 hours prior to the procedure 
and was restarted 6 hours after the procedure if there was no evidence of surgical site 
bleeding. For major procedures (non-emergent), heparin was stopped 6 hours prior to 
the procedure to minimize intra-operative bleeding. Heparin was routinely restarted 24 
hours post-procedure unless bleeding or the bleeding risk is excessively high due to 
extensiveness of the procedure, then anticoagulation was held an additional 24 hours 
and re-evaluated .   
A summary of patient and ECMO data are found in Table 1. 
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CASE REPORTS 
Case #1: Aspiration pneumonia/ ARDS 
A 17 year-old-male was admitted with a cervical injury and subsequently suffered an 
aspiration event.  He developed pneumonia progressing to adult respiratory distress 
syndrome (ARDS), and a right-sided pneumothorax. A chest tube was placed at the 
bedside, and subsequently VV ECMO using the Avalon Cannula was initiated. Heparin 
was administered at the time of ECMO cannula insertion and a heparin drip was started 
24 hours after initiating ECMO titrating PTT to 45-55. He developed a right-sided 
hemothorax after ECMO cannulation, prompting a series of three right video assisted 
thoracoscopies (VATS) with washout of the right chest and multiple chest tube 
placements. Anticoagulation was held 6 hours prior to the VATS and restarted 24 hours 
after surgery, with adjusted PTT of 40-45. Over the subsequent 2 days, blood 
accumulated in the right chest, despite low therapeutic PTTs, requiring definitive 
hemostasis via a right posterior-lateral thoracotomy and control of chest wall 
hemorrhage. Bleeding was secondary to muscle and chest wall perforators. His 
resuscitation involved transfusion of 39 units of PRBC and 25 units of platelets. ECMO 
was weaned after 10 days, requiring a total of 2 ECMO circuit exchanges. He was later 
discharged to rehab, able to tracheal collar and tolerate oral intake.   
Case #2: Aspiration pneumonia/ ARDS 
A 21 year-old-female with an inhalational overdose of formaldehyde developed 
progressive respiratory acidosis and hypoxia. VA ECMO was initiated for an atrial septal 
defect and acidosis. Several bronchoscopies were performed for endobronchial clot and 
multiple chest tubes placed for pneumothoraces and loculated empyema. Two left-sided 
thoracotomies were necessary with clot removal and chest tube placements.  An 
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exploratory laparotomy was performed for free intraperitoneal air, ultimately attributed to 
pneumothoraces. She received a right VATS with chest tube placements for a persistent 
pneumothorax. A tracheostomy and percutaneous gastrostomy tube were placed while 
on ECMO. For surgical interventions, anticoagulation was held 6-24 hours based on the 
extensiveness of surgery, with a goal PTT 40-45 due to bleeding complications.  Her 
length of stay on ECMO was 26 days, with 3 ECMO oxygenator exchanges and 
transfusion of 96 units of PRBC with 130 units of platelets during her resuscitation. Upon 
discharge to rehab, this patient was trach collaring and tolerating tube feeds. She had no 
oxygen requirements at her 2 months office visit. 
Case #3: Empyema/ ARDS 
A 47 year-old-male presented with an empyema warranting bedside chest tube 
placement. An expanding hemothorax developed, progressing to ARDS.  VA-ECMO was 
initiated due to progressive acidosis and hypoxemia, followed by a thoracotomy to 
temporize bleeding. Two additional thoracotomies were performed for recurrent 
hemothoraces. Due to the evolution of lung abscesses and sepsis, a pneumonectomy 
and tracheostomy were performed. Anticoagulation was held 6-24hours peri-operatively. 
His was maintained on ECMO for 9 days, required one circuit exchange, 62 units of 
PRBC, 12 units of FFP, 10 units of platelets and 20 units of cryoprecipitate during 
resuscitation. He was discharged to a rehab facility, tracheal collaring. 
Case #4: Aspiration pneumonia/ ARDS 
A 48 year-old-male was found unconscious after a drug overdose with an aspiration 
event and subsequently developed ARDS. He was placed on VA ECMO for worsening 
respiratory acidosis and inability to oxygenate. While on ECMO, he had a disruption of 
his left femoral artery during positioning of the distal perfusion cannula requiring washout 
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of a thigh hematoma, repair of femoral artery pseudoaneurysm and replacement of the 
distal perfusion catheter. Heparin was held 12 hours post-procedure.  Post-operatively, 
this patient was noted to have gastrointestinal bleeding. Upper and lower endoscopies 
were performed without identification of the bleeding site. A push enteroscopy identified 
a jejunal bleeding site which was coagulated under the push endoscopy.  The heparin 
was held 6 hours before gastrointestinal procedures and additional 6 hours after 
procedures. He remained on ECMO for 13 days, requiring no oxygenator exchanges, 
received 36 units of PRBC with 25 units of platelets. He was discharged to a 
rehabilitation facility tracheal collaring and tolerating tube feeds. 
Case #5: Progressive viral pneumonia 
A 53 year old female was admitted with worsening respiratory distress due to a viral 
illness. She was placed on VV ECMO using the Avalon Elite Dual Lumen Cannula via 
right internal jugular vein. During cannulation, a pericardial effusion was diagnosed by 
transthoracic echocardiography, warranting immediate bedside pericardial window and 
operative repair of cannula-related right ventricular rupture. Two mediastinal washouts 
with packing were required until mediastinum closure at the time of her ECMO withdraw 
on day 9. Heparin was held 6-24 hours after each sternal intervention. Her resuscitation 
involved 42 units of PRBC, 14 units of FFP and 80 units of platelets. She was 
discharged home in 24 days with no oxygen requirements and adequate oral intake.    
 
 
DISCUSSION 
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The first successful use of ECMO for respiratory support was reported in 1972 by 
Hill et al. 4 An early clinical trial demonstrated poor survival and a large blood loss 
(>2.5L/day) in VA ECMO supported patients for respiratory failure. 5 Despite 
improvements in circuit related technology, lung protection techniques and eligibility 
requirements, survival rates have not exceed 50-52% in this high risk population.6,7, 8, 9   
Poor survival, as demonstrated, may be related to hemorrhagic complications, which are 
frequently seen in the ECMO population. 
Bleeding is a common complication in ECMO supported patients contributing in 
part to the overall poor survival in this population.2 Contact of blood with ECMO circuitry 
leads to an intense pro-inflammatory and pro-thrombotic state, initiating the clotting 
cascade with activation of kininogen, kallikrein, factor XII, and platelets. This leads to 
activation of thrombin, factor XII and tissue plasminogen to counteract the clotting 
cascade. 2A decrease in platelets occurs, attributable to decreased production, 
increased consumption, sequestration, and dilution.The ongoing pro-coagulant and 
anticoagulant activity can lead to an imbalance of factors, resulting in thrombosis or 
hemorrhage and DIC.10 
Due to the risk of clot formation with patients on ECMO, anticoagulation is 
necessary with the goal of preventing thrombosis while avoiding excessive bleeding. 
Historically, a fixed dose of heparin was employed as done with cardiopulmonary 
bypass, and anticoagulation with heparin was attained using a high therapeutic level of 
PTT (60-80sec) or activated clotting time (ACT>180-240) to prevent thrombosis.10 Newer 
circulatory systems utilizing a heparin bonded tubing, a low pressure oxygenator and 
centrifugal pump allows for maintenance of anticoagulation on ECMO to be lower 
without thrombotic complications. VV ECMO may be maintained using heparin bonded 
tubing without administration of systemic heparin; however, in our experience clot 
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formation in the cannulas and oxygenator is common often necessitating circuit 
exchange, increased expense and risk for systemic thrombosis or embolism. The ELSO 
Guidelines continue to recommend anticoagulation to prevent thrombotic 
complications.11Our practice no longer uses ACT for titration of heparin due to 
unreliability10; PTT levels are monitored with point of care testing.10, 12 
Sources of bleeding while on ECMO are varied and may be related to pre-ECMO 
procedures, may occur during ECMO cannulation, or as a result of prolonged 
cannulation, as evidenced by our series of patients.  Bleeding complications related to 
pre-ECMO chest tube placement were common in this series.  The majority of patients 
(Cases 1,2 and 3) had a chest tube placed prior to ECMO for barotrauma induced 
pneumothoraces and was subsequently anticoagulated during cannulation.  These 
patients experienced chest wall hemorrhage at the site of chest tube insertion requiring 
surgical intervention within 24 hours of ECMO cannulation. In two of these cases, VATS 
were initially attempted to minimize bleeding risks when patients were anticoagulated, 
although definitive thoracotomies were eventually necessary in all three cases.  
Cardiovascular structural damage may occur during placement of venous and/or 
arterial cannulas, as previously described by our group13.  As observed in Case #5, 
bedside placement of an Avalon catheter with the use of transthoracic echocardiography 
(TTE) may inadequately detect the guide-wire in the inferior vena cava during cannula 
placement which could result in myocardial injury. Transesophageal echocardiography 
may be required in conjunction with TTE to facilitate guide-wire and cannula 
placement.14, 15   Patients who are stable should undergo fluoroscopic guidance for 
venous access. 
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Management of the post-cardiotomy and post-thoracotomy open chest can be 
challenging, as experienced in this same Case #5. Initiation of the low dose heparin 
protocol and cessation of heparin perioperative resulted in reduction in perioperative 
bleeding and allowed successful wound closure. Importantly there were no circuit related 
thrombotic or neurological complications in these patients. 
Gastrointestinal bleeding from an arterio-venous malformation while on ECMO 
occurred in the patient in Case #4 and has recently been described by our group.16 The 
etiology of this bleeding may be related to the lack of the arterial pulsatility in mesenteric 
perfusion.  Options for identification of bleeding include upper and lower endoscopy and 
capsule studies. Our patient had a full diagnostic workup on ECMO while heparin was 
held for 48 hours; multiple sites of bleeding were found in the jejunum and push 
enteroscopy with coagulation was successful. 
 Although our small patient population may limit our results, we experienced no 
circuit related complications associated with the initiation or cessation of anticoagulation 
for bleeding complications, such as acute circuit thrombosis or systemic emboli, while 
following our anticoagulation protocol. The number of circuit exchanges due to poor 
oxygenation was minimal. The bedside circuit exchange was a simple procedure which 
did not require additional heparin bolus. No thrombotic complications were encountered 
during or after circuit exchange. 
Success and survival in patients undergoing multiple surgical interventions while 
on ECMO have not been reported except in a single patient case report.17 Bleeding 
remains a major source of morbidity and mortality in the ECMO supported patient, 
particularly when surgical or endoscopic intervention is necessary.  Successful control of 
bleeding and survivalwas attributed in part to advancements in ECMO circuitry, use of 
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an anticoagulation protocol and an aggressive surgical approach to resolve bleeding in 
this high risk population.   
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